Pharmaceuticals

The U.S. Food and Drug Administration today announced the agency is working with Abbott Diabetes Care (NYSE: ABT) to recall 359 different lots of glucose test strips marketed under the following brand names: Precision Xceed Pro; Precision Xtra; Medisense Optium; Optium; OptiumEZ; and...

Here's what Benzinga's reading on our friend, TheStreet.com. What's Hot On TheStreet 2011 Big-Cap Biotech Preview Biotech investors looking for outsized returns in 2010 failed to find them in "Big Five" large-cap biotech stocks. Only Genzyme (NASDAQ: GENZ) and Biogen Idec (NASDAQ: BIIB) yielded...

Recently, Incyte Corporation (INCY) announced positive top-line data on pipeline candidate INCB18424 (also known as INC424) from a pivotal phase III trial, COMFORT-I. COMFORT-I was conducted to study INCB18424 for the treatment of patients with myelofibrosis (MF), a rare bone marrow disorder. The...

Recently, Incyte Corporation (INCY) announced positive top-line data on pipeline candidate INCB18424 (also known as INC424) from a pivotal phase III trial, COMFORT-I. COMFORT-I was conducted to study INCB18424 for the treatment of patients with myelofibrosis (MF), a rare bone marrow disorder. The...

Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) are barely up, gaining 4 cents to $4.23, but had been as high as $4.68 earlier in the session on the back of seemingly positive FDA endpoint news earlier today. The company said that its drug Corlux, which is used for Cushing's Syndrome, is...

Unconfirmed Rumors Circulate that Neurocrine Biosciences Inc. (NBIX) will be taken out by Eli Lilly & Co. (LLY) at $17.00 a share.

AstraZeneca (AZN) suffered another pipeline setback recently with the company announcing that it no longer intends to develop motavizumab for the prophylaxis of serious respiratory syncytial virus (RSV) disease. The company has requested the US Food and Drug Administration (FDA) to withdraw the...

Eli Lilly and Company (LLY) recently announced the completion of the acquisition of privately-held company, Avid Radiopharmaceuticals, Inc. for an upfront payment of $300 million. In addition to this upfront payment, Eli Lilly may have to pay up to $500 million on the achievement of certain...

Eli Lilly and Company (LLY) recently announced the completion of the acquisition of privately-held company, Avid Radiopharmaceuticals, Inc. for an upfront payment of $300 million. In addition to this upfront payment, Eli Lilly may have to pay up to $500 million on the achievement of certain...

AstraZeneca (AZN) suffered another pipeline setback recently with the company announcing that it no longer intends to develop motavizumab for the prophylaxis of serious respiratory syncytial virus (RSV) disease. The company has requested the US Food and Drug Administration (FDA) to withdraw the...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its partner Pfizer, Inc. (NYSE: PFE) has granted a sublicense to a multi-national pharmaceutical company for Tanaproget, also known as NSP-989. As a result, Ligand will receive an upfront payment of $1 million from Pfizer....

Corcept Therapeutics Incorporated (NASDAQ: CORT) is up over 60% today after announcing positive top-line results from its Phase 3 study of CORLUX for the treatment of Cushing's Syndrome. The study evaluated the response of two patient groups to CORLUX treatment: one included patients who were...

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)-- Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that the companies have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European...

We reiterate our Outperform rating on eye-care and surgical products maker Cooper Companies Inc (COO) following its strong fourth-quarter and fiscal 2010 results and management's upbeat guidance. Revenues and earnings for the quarter and fiscal year beat the Zacks Consensus Estimate, boosted by...

We reiterate our Outperform rating on eye-care and surgical products maker Cooper Companies Inc (COO) following its strong fourth-quarter and fiscal 2010 results and management's upbeat guidance. Revenues and earnings for the quarter and fiscal year beat the Zacks Consensus Estimate, boosted by...